IACCARINO, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 3.087
AS - Asia 1.754
EU - Europa 967
SA - Sud America 915
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.810
Nazione #
US - Stati Uniti d'America 3.003
BR - Brasile 813
SG - Singapore 632
CN - Cina 515
IT - Italia 242
UA - Ucraina 229
VN - Vietnam 192
DE - Germania 128
HK - Hong Kong 112
GB - Regno Unito 58
SE - Svezia 58
FI - Finlandia 57
FR - Francia 55
IN - India 44
BD - Bangladesh 35
TR - Turchia 34
MX - Messico 33
KR - Corea 30
AR - Argentina 27
CA - Canada 26
RU - Federazione Russa 26
IQ - Iraq 25
ZA - Sudafrica 23
EC - Ecuador 22
PL - Polonia 22
NL - Olanda 21
JP - Giappone 19
BE - Belgio 16
PK - Pakistan 16
UZ - Uzbekistan 16
CO - Colombia 13
ID - Indonesia 12
MA - Marocco 12
SA - Arabia Saudita 12
ES - Italia 11
VE - Venezuela 11
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 9
CZ - Repubblica Ceca 7
JO - Giordania 7
UY - Uruguay 7
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
AZ - Azerbaigian 5
EG - Egitto 5
PE - Perù 5
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
SN - Senegal 4
AO - Angola 3
DO - Repubblica Dominicana 3
EU - Europa 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GR - Grecia 1
IE - Irlanda 1
IM - Isola di Man 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
ML - Mali 1
NG - Nigeria 1
Totale 6.806
Città #
Dallas 1.313
Singapore 331
Chandler 303
San Jose 199
Jacksonville 137
Ashburn 134
Beijing 127
Hong Kong 110
Sassari 90
Princeton 84
Ho Chi Minh City 70
Nanjing 64
Ann Arbor 62
New York 51
São Paulo 48
Lauterbourg 45
Shanghai 44
Dearborn 37
Hanoi 36
Los Angeles 32
Seoul 30
Wilmington 29
Nanchang 27
Santa Clara 27
Belo Horizonte 22
Helsinki 22
Boardman 21
Shenyang 21
Frankfurt am Main 20
Rio de Janeiro 20
Tianjin 20
Jinan 19
Warsaw 19
Council Bluffs 17
Tokyo 17
Brussels 16
Tashkent 16
Hebei 15
Johannesburg 15
Curitiba 14
Orem 14
Poplar 14
Woodbridge 14
Changsha 13
Munich 13
Stockholm 13
San Francisco 12
Chicago 10
Da Nang 10
Guangzhou 10
Mexico City 10
Rome 10
Zhengzhou 10
Brasília 9
Brooklyn 9
Campo Grande 9
Haiphong 9
Mountain View 9
Ningbo 9
Toronto 9
Baghdad 8
Betim 8
Boston 8
Cagliari 8
Campinas 8
Columbus 8
Denver 8
Dhaka 8
Guarulhos 8
Joinville 8
Mumbai 8
Nairobi 8
Niterói 8
Pelotas 8
Quito 8
Salvador 8
Amsterdam 7
Chennai 7
Guayaquil 7
Istanbul 7
Juiz de Fora 7
Norwalk 7
Porto Alegre 7
Ribeirão Preto 7
The Dalles 7
Amman 6
Atlanta 6
Bragança Paulista 6
Cotia 6
Haikou 6
Houston 6
Izmir 6
Jeddah 6
Lappeenranta 6
Manchester 6
Montevideo 6
Montreal 6
Nuremberg 6
Osasco 6
Sumaré 6
Totale 4.221
Nome #
null 509
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 248
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors 195
Prune melanoidins protect against oxidative stress and endothelial cell death 188
ALTERATION IN VESICLE TRAFFICKING IN PARKINSON’S DISEASE: FROM PATHOLOGICAL MOLECULAR MECHANISMS TO THERAPEUTIC OPTION 188
Role of LRRK2 in the regulation of dopamine receptor trafficking. 183
Epigenetic changes associated with the expression of Amyotrophic Lateral Sclerosis (ALS) causing genes 181
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8 181
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype 166
AMYOTROPHIC LATERAL SCLEROSIS AND TDP-43: AN EPIGENETIC LIAISON 165
Cyanotoxins exposure and TDP-43 physiopathology: a molecular study 163
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis 152
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON DOPAMINE METABOLISM IN PC12 CELLS 144
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities 144
Alternative splicing of pro- and anti-apoptotic genes in amyotrophic lateral sclerosis 144
Dual control of dopamine synthesis and release by pre- and postsynaptic dopamine D2 receptors 142
Apoptotic mechanisms in mutant LRRK2-mediated cell death 142
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 142
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways 142
Functional analysis of TDP43: interaction with the epigenetic machinery 141
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 138
Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases 138
Control of Lactotrop Proliferation by Dopamine: Essential Role of Signalling Through D2 Receptors and ERKs 137
Cyanobacteria, cyanotoxins, and neurodegenerative diseases: Dangerous liaisons 133
Astroglial inhibition of NF-kappaB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) 132
Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for Amyotrophic Lateral Sclerosis (ALS) 131
Inhibition of receptor-dependent urokinase signalling by specific Ser to Glu substitutions 127
Neurobiological features of dopamine D2 receptors. Distinct functions of D2L and D2S in vivo 124
Bcl2a1 role in familial Amyotrophic Lateral Sclerosis (ALS) 120
GFP-based reporters to monitor biochemical alteration in cellular models for Amyotrophic Lateral Sclerosis 118
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease 117
Role of LRRK2 in the regulation of dopamine receptor trafficking 117
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity 112
Natural polyphenols for one pot green synthesis and stabilization of gold nanoparticles with antioxidant and biological activities 109
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 107
Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility 106
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models 105
Understanding the function of dopamine D2 receptor : A knock-out animal approach 104
LRRK2 and vesicle trafficking 99
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects 97
Regulatory roles of hnRNP M and Nova-1 in the alternative splicing of the dopamine D2 receptor pre-mRNA 95
SOD1-LINKED FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS: UNDERSTANDING THE TOXIC FUNCTION OF THE MUTANT ENZYMES 94
Parkinson’s disease-related genes and lipid alteration 93
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy 91
PROTEIN KINASE C-DEPENDENT IN VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST 90
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 81
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 78
Prune melanoidins protect endothelial cell against oxidative stress and mitochondria-mediated cell death 75
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner 69
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 39
Cyanobacteria and cyanotoxins: a long history of studies in Sardinia (Italy) 33
Totale 6.869
Categoria #
all - tutte 24.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.548


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022261 23 2 7 5 2 9 8 12 36 40 27 90
2022/2023542 50 61 15 94 45 86 4 66 79 5 27 10
2023/2024218 24 13 2 8 24 35 24 5 0 11 34 38
2024/20251.665 7 8 102 49 80 65 120 315 514 262 93 50
2025/20263.145 139 400 1.094 385 244 160 376 60 87 131 38 31
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 6.869